Lux Health Tech Acquisition Corp. (Nasdaq: LUXA) is a blank-check company sponsored by an affiliate of Lux Capital Management, the science and deep-technology venture firm, and was formed to pursue a business combination in the health technology sector. The SPAC completed its initial public offering in 2021 and subsequently traded on Nasdaq while conducting its search for a merger target. In October 2022 the company filed an 8-K with the Securities and Exchange Commission, reflecting a material corporate development during its active search period. LUXA represents one of a wave of health-focused SPACs that came to market amid heightened investor interest in digital health and life-science technology. For complete deal history, filing documents, and real-time status on LUXA and hundreds of other SPACs, sign up for full data access at SpacDesk.